A versatile supramolecular nanoadjuvant that activates NF- κ B for cancer immunotherapy

Conclusion: These findings demonstrate that 3DSNA is a promising neo-adjuvant that enables various vaccines to be therapeutic for many important diseases including cancer.

Source: Theranostics - June 13, 2019 Category: Molecular Biology Authors: Yan Xu, Youzhi Wang, Quanli Yang, Zhijia Liu, Zhiqiang Xiao, Zhicheng Le, Zhimou Yang, Chengbiao Yang Tags: Research Paper Source Type: research